Phase I Neoadjuvant Study of Intravesical Recombinant Fowlpox-GM-CSF (rF-GMCSF) or Fowlpox-TRICOM (rF-TRICOM) in Patients with Bladder Carcinoma

Intravesical BCG is a highly effective treatment for high-grade non-muscle invasive bladder cancer and carcinoma in situ (CIS); however, for patients who are either resistant or become unresponsive to BCG therapy there is a need for alternative treatment approaches. This study examined the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Portal, Daniella E., Weiss, Robert E., Wojtowicz, Malgorzata, Mansour, Amal, Monken, Claude, Mehnert, Janice M., Aisner, Joseph A., Kane, Michael, Nishioka, Jennifer, Aisner, Seena, Peters, Stephen, Stein, Mark N., Kim, Isaac Y., Mayer, Tina M., Shih, Weichung, Gulley, James, Streicher, Howard, Singer, Eric A., Lattime, Edmund C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923616/
https://www.ncbi.nlm.nih.gov/pubmed/31222182
http://dx.doi.org/10.1038/s41417-019-0112-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923616/
https://www.ncbi.nlm.nih.gov/pubmed/31222182
http://dx.doi.org/10.1038/s41417-019-0112-z

Ejemplares similares